Tomomi Sanomachi, Tatsunori Shimoi, Yuki Kojima, Hideaki Takahashi, Motoko Arakaki, Asuka Kawachi, Hitomi Sumiyoshi Okuma, Mai Hoshino, Munehiro Ito, Ayumi Saito, et al. Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based Therapy. Head & neck. 2025
Sho Sato, Shigehiro Yagishita, Hiroshi Yoshida, Daisuke Shintani, Aiko Ogasawara, Tadaaki Nishikawa, Masanori Yasuda, Keiji Furuuchi, Toshimitsu Uenaka, Akinobu Hamada, et al. Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling. Neoplasia (New York, N.Y.). 2025. 64. 101158-101158
Taro Yamanaka, Tadaaki Nishikawa, Hiroshi Yoshida. Development of Antibody-Drug Conjugates for Malignancies of the Uterine Corpus: A Review. Cells. 2025
Best of ESMO 2024 On Demand in Japan
(日本臨床腫瘍学会教育委員会Best of ESMO 部会 2024)
Management of Metastatic and Recurrent Cervical Cancer
(アジア婦人科腫瘍学会2025 2024)
OSCAR trial (NCCH1510) Efficacy and safety of nivolumab in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma A multicenter, phase 2 clinical trial
(アジア婦人科腫瘍学会2025 2024)